The investigation of galectin-3 in diseases of the thyroid gland

European Journal of Endocrinology

Volumn 149, Issue 5, 2003, Pages 449-453

  Kovács, Rita Béata ^a   Földes, János ^a   Winkler, Gábor ^a   Bodó, Miklós ^a   Sápi, Zoltán ^a  

^a ST JOHN'S HOSPITAL   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3; PEROXIDASE;

ADENOSQUAMOUS CARCINOMA; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ENZYME MECHANISM; FOLLICULAR CARCINOMA; GOITER; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SUBACUTE THYROIDITIS; THYROID DISEASE; THYROID GLAND; THYROID TUMOR; TUMOR CLASSIFICATION;

ADENOMA; ADENOMA, OXYPHILIC; CARCINOMA, PAPILLARY, FOLLICULAR; DIAGNOSIS, DIFFERENTIAL; GALECTIN 3; HUMANS; IMMUNOENZYME TECHNIQUES; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROID NODULE; THYROIDITIS, AUTOIMMUNE; TUMOR MARKERS, BIOLOGICAL;

EID: 0344897784     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1490449     Document Type: Article

References (33)

1. Gaudin JC, Mehul B & Hughes RC. Nuclear localization of wild type and mutant galectin-3 in transfected cells. Biology of the Cell 2000 92 49-58.
2. Hadari YR, Arbel-Goren R, Levy Y, Amsterdam A, Alon R, Zakut R et al. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. Journal of Cell Science 2000 113 2385-2397.
3. Inohara H, Akahani S & Raz A. Galectin-3 stimulates cell proliferation. Experimental Cell Research 1998 245 294-302.
4. Matarresea P, Tinari N, Semeraroa ML, Natolib C, Jacobelli S & Malorni W Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Letters 2000 473 311-315.
5. Matarrese P, Fusco O, Tinari N, Natoli C, Liu FT, Semeraro ML et al. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. International Journal of Cancer 2000 85 545-554.
6. Fernandez PL, Merino MJ, Gomez M, Campo E, Medina T, Castronovo V et al. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. Journal of Pathology 1997 181 80-86.
7. Perillo NL, Marcus ME & Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation and cell death. Journal of Molecular Medicine 1998 76 402-412.
8. Sotomayor CE & Rabinovich GA. Galectin-1 induces central and peripheral cell death: implications in T-cell physiopathology, Development Immunology 2000 7 117-129.
9. Yoshii T, Inohara H, Takenaka Y, Honjo Y, Akahani S, Nomura T et al. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. International Journal of Oncology 2001 18 787-792.
10. Nakamura M, Inufusa H, Adachi T, Aga M, Kurimoto M, Nakatani Y et al. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. International Journal of Oncology 1999 15 143-148.
11. Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. American Journal of Pathology 2000 156 899-909.
12. Plzak J, Smetana K Jr, Hrdlickova E, Kodet R, Holikova Z, Liu FT et al. Expression of galectin-3 reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation. International Journal of Oncology 2001 19 59-64.
13. Baldus SE, Zirbes TK, Weingarten M, Fromm S, Glossmann J & Hanisch FG. Increased galectin-3 expression in gastric cancer: correlations with histopathological subtypes, galactosylated antigens and tumour cell proliferation. Tumour Biology 2000 21 258-266.
14. Honjo Y, Nangia-Makker P, Inohara H & Raz A. Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clinical Cancer Research 2001 7 661-668.
15. Sanjuan X, Fernandez PL, Castells A, Castronovo V, van den Brule F, Liu FT et al. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology 1997 113 1906-1915.
16. Konstantinov KN, Robbins BA & Liu FT. Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma. American Journal of Pathology 1996 148 25-30.
17. Cvejic D, Savin S, Paunovic I, Tatic S, Havelka M & Sinadinovic J. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer 'Research 1998 18 2637-2641.
18. Niedobitek C, Niedobitek F, Lindenberg G, Bachler B, Neudeck H, Zuschneid W et al. Expression of galectin-3 in thyroid gland and follicular cell tumors of the thyroid. A critical study of its possible role in preoperative differential diagnosis. Pathologe 2001 22 205-213.
19. Rosahl SK, Erpenbeck V, Vorkapic P & Samii M. Solitary follicular thyroid carcinoma of the skull base and its differentiation from ectopic adenoma - review, use of galectin-3 and report of a new case. Clinical Neurology and Neurosurgery 2000 102 149-155.
20. Beesley MF & McLaren KM. Cytokeratin 19 and galectin-3 immunhistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology 2002 41 236-243.
21. Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG & Bartolazzi A. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. Journal of Clinical Oncology 1999 17 3494-3502.
22. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001 357 1644-1650.
23. Saggiorato E, Cappia S, Giuli P, Mussa A, Pancani G, Caraci P et al. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2001 86 5152-5158.
24. Nascimento MC, Bisi H, Alves VA, Longatto-Filho A, Kanamura CT & Medeiros-Neta G. Differential reactivity for galectin-3 in Hurthle cell adenomas and carcinomas. Endocrine Pathology 2001 1 275-279.
25. Coli A, Bigotti G, Zucchetti F, Negro F & Massi G. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 2002 40 80-87.
26. Kawachi K, Matsushita Y, Yonezawa S, Nakano S, Shirao K, Natsugoe S et al. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Human Pathology 2000 31 428-433.
27. Cvejic D, Savin S, Golubovic S, Paunovic I, Tatic S & Havelka M. Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: possible relation to tumour progression. Histopathology 2000 37 530-535.
28. Rabinovich GA & Rubinstein N. Galectins: a novel family of proteins involved in the regulation of the immune response. Implications in immunopathological processes. Medicine 2001 61 85-92.
29. Papotti M, Volante M, Saggiorato E, Deandreio D, Veltri A & Orlandi F. Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. European Journal of Endocrinology 2001 147 515-521.
30. Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU & Kimura ER. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumor. Journal of Clinical Endocrinology and Metabolism 2002 87 4806-4810.
31. Niedziela M, Maceluck J & Korman E. Galectin-3 is not a universal marker of malignancy in thyroid nodular disease in children and adolescents. Journal of Clinical Endocrinology and Metabolism 2002 87 4411-4415.
32. Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K et al. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 1999 85 2475-2484.
33. Iurisci I, Tinari N, Natoli C, Angelucci D, Cianchetti E & Iacobelli S. Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clinical Cancer Research 2000 4 1389-1393.